Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

☰

Bicycle Therapeutics Snags $52 Million to Take Early Stage Drugs Into Clinic

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"Bicycle Therapeutics Snags $52 Million to Take Early Stage Drugs Into Clinic" ALT"Bicycle Therapeutics Snags $52 Million to Take Early Stage Drugs Into Clinic"June 1, 2017By Alex Keown,…

Continue ReadingBicycle Therapeutics Snags $52 Million to Take Early Stage Drugs Into Clinic

Massachusetts' Deciphera Banks $52 Million to Advance Oncology Pipeline

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"Massachusetts' Deciphera Banks $52 Million to Advance Oncology Pipeline" ALT"Massachusetts' Deciphera Banks $52 Million to Advance Oncology Pipeline"June 1, 2017By Alex Keown, BioSpace.com Breaking... Source: BioSpace

Continue ReadingMassachusetts' Deciphera Banks $52 Million to Advance Oncology Pipeline

Akari CEO Abruptly Steps Down Amid Investigation Into Phase II Trial Data

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-personnel-leaving.jpg" NAME"Akari CEO Abruptly Steps Down Amid Investigation Into Phase II Trial Data" ALT"Akari CEO Abruptly Steps Down Amid Investigation Into Phase II Trial Data"May 31, 2017By Alex Keown,…

Continue ReadingAkari CEO Abruptly Steps Down Amid Investigation Into Phase II Trial Data

Spectacular Data Posted for Novartis AG's Next Generation CAR-T Drug

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x400-novartis.jpg" NAME"Spectacular Data Posted for Novartis AG's Next Generation CAR-T Drug" ALT"Spectacular Data Posted for Novartis AG's Next Generation CAR-T Drug"May 31, 2017By Mark Terry, BioSpace.com Breaking News Staff...…

Continue ReadingSpectacular Data Posted for Novartis AG's Next Generation CAR-T Drug